Drug Topics e-News:
Having trouble viewing this email? View in a browser.
|
You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.
|
to Drug Topics e-News
|
|
|
|
 |
 |
Newest: Medication errors: Causes, prevention, liability, and the apology
|
| For pharmacists, from Drug Topics: Continuing education for pharmacists and pharmacy technicians. Go to CE site here |
|
|
|
|
Survey
This month we would like to know...
Does your pharmacy use social media (blog, Facebook, Twitter, etc.) as a marketing tool?
• Yes
• No
• We plan on using social media in 2011
|
|
|
The ACP guideline, published in the Annals of Internal Medicine, seeks to end uncertainty regarding the therapy and the optimal glucose range to target in these patients. Read full article. |
 |
|
|
 |
A monthly review of the peer-reviewed literature by
Drug Topics' Editorial Advisor
Anna D. Garrett, PharmD, BCPS. Anna Garrett is manager, Outpatient Clinical Pharmacy Programs, Mission Hospital, Asheville, N.C.
|
Benefit of compression stockings after stroke is modest
Read full article.
|
According to a survey published in the March issue of the Journal of Clinical Nursing, nearly two-thirds of hospital in-patients had experienced pain in the previous 24 hours, and 42% of those rated their pain as more than 7 out of 10. Read full article. |
|
|
A new study published in Science Translational Medicine found that patients' expectations regarding the effects of pain medications influence medication efficacy as well as the pain-related brain pathways activated during treatment. Read full article.
|
|
FDA approved the first-and-only selective phosphodiesterase type 4 inhibitor roflumilast (Daliresp, Forest Pharmaceuticals), once-daily oral tablet to decrease the frequency of exacerbations or worsening of symptoms from severe COPD. Read full article.
|
|
Rheumatoid arthritis patients who have been treated with glucocorticoids have an increased risk of gastrointestinal perforation, according to a study published in Arthritis & Rheumatism. Read full article.
|
|
FDA approved azilsartan medoxomil tablets (Edarbi, Takeda Pharmaceutical North America) to treat hypertension in adults. Read full article.
|
|
Tifacogin does not appear to improve outcomes of patients with severe community-acquired pneumonia, according to a global study published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine. Read full article.
 |
Meetings and Events
March 13-15, 2011 NACDS Supply Chain & Logistics Conference
San Diego, CA
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-683-5678
March 14-17, 2011 The 35th International Good Manufacturing Practices Conference
On spotlighting GMP enforcement
Athens, GA
Contact:
Gary Dykstra
678-985-6827
gdykstra@rx.uga.edu
March 24, 2011 Regional NACDS-DEA Meeting
10:00 a.m.-3:00 p.m.
Houston, Texas
Contact:
Magalie Normil
413 North Lee Street
Alexandria, VA
22313-1480
mnormil@nacds.org
March 25-28, 2011 American Pharmacists Annual Meeting
Seattle, WA
Contact:
2215 Constitution Avenue, NW
Washington, DC 20037
Phone: 1-800-237-2742 (APhA)
Fax: 202-448-8734
|
|
|
| Congratulations to Shawn Ackerman, Walgreens, Bristol, R.I., for winning the $100 gift card for participating in the January Drug Topics' reader survey. |
|
|
| Contact Us |
Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here |
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
 Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
